Ascentage Pharma Group International - ADR
:AAPG 3:58:03 PM EDT
| Market Cap (Intraday) | 1.99B |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $20.59 |
| 50-Day MA | $23.25 |
| 200-Day MA | $30.07 |
Ascentage Pharma Group International - ADR Stock, :AAPG
Suzhou Industrial Park, 68 Xinqing Road, Suzhou, Jiangsu 215000
China
Phone: +86.512.85557777
Number of Employees: 583
Description
Ascentage Pharma Group International Co., Ltd. is a clinical-stage biotechnology company. It engages in the development of novel therapies for cancers, hepatitis B virus, or HBV, and age-related diseases. The company was founded by Da Jun Yang, Wang Shao Meng and Ming Guo in May 2009 and is headquartered in Suzhou, China.


